139 related articles for article (PubMed ID: 23713966)
1. Dopamine d(1)-like receptors suppress proliferation of vascular smooth muscle cell induced by insulin-like growth factor-1.
Kou X; Han Y; Yang D; Liu Y; Fu J; Zheng S; He D; Zhou L; Zeng C
Clin Exp Hypertens; 2014; 36(3):140-7. PubMed ID: 23713966
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of D1-like dopamine receptors on neuropeptide Y-induced proliferation in vascular smooth muscle cells.
Zhou Y; Shi W; Luo H; Yue R; Wang Z; Wang W; Liu L; Wang WE; Wang H; Zeng C
Hypertens Res; 2015 Dec; 38(12):807-12. PubMed ID: 26178154
[TBL] [Abstract][Full Text] [Related]
3. D1-like receptors inhibit insulin-induced vascular smooth muscle cell proliferation via down-regulation of insulin receptor expression.
Zeng C; Han Y; Huang H; Yu C; Ren H; Shi W; He D; Huang L; Yang C; Wang X; Zhou L; Jose PA
J Hypertens; 2009 May; 27(5):1033-41. PubMed ID: 19293728
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of D1-like and D3 dopamine receptors on norepinephrine-induced proliferation in vascular smooth muscle cells.
Li Z; Yu C; Han Y; Ren H; Shi W; Fu C; He D; Huang L; Yang C; Wang X; Zhou L; Asico LD; Zeng C; Jose PA
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2761-8. PubMed ID: 18441198
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D1-Like Receptors Suppress the Proliferation of Macrophages Induced by Ox-LDL.
Yao Y; Yang D; Han Y; Wang W; Wang N; Yang J; Zeng C
Cell Physiol Biochem; 2016; 38(1):415-26. PubMed ID: 26824460
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
7. Mechanical stretch augments insulin-induced vascular smooth muscle cell proliferation by insulin-like growth factor-1 receptor.
Liu G; Hitomi H; Hosomi N; Lei B; Nakano D; Deguchi K; Mori H; Masaki T; Ma H; Griendling KK; Nishiyama A
Exp Cell Res; 2011 Oct; 317(17):2420-8. PubMed ID: 21854769
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species.
Meng D; Shi X; Jiang BH; Fang J
Free Radic Biol Med; 2007 Jun; 42(11):1651-60. PubMed ID: 17462533
[TBL] [Abstract][Full Text] [Related]
9. Endothelial insulin-like growth factor-1 modulates proliferation and phenotype of smooth muscle cells induced by low shear stress.
Wang L; Han Y; Shen Y; Yan ZQ; Zhang P; Yao QP; Shen BR; Gao LZ; Qi YX; Jiang ZL
Ann Biomed Eng; 2014 Apr; 42(4):776-86. PubMed ID: 24322591
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone I inhibits vascular smooth muscle cell proliferation by targeting insulin-like growth factor-1 receptor/phosphatidylinositol-3-kinase signaling pathway.
Wu YT; Bi YM; Tan ZB; Xie LP; Xu HL; Fan HJ; Chen HM; Li J; Liu B; Zhou YC
Eur J Pharmacol; 2019 Jun; 853():93-102. PubMed ID: 30878387
[TBL] [Abstract][Full Text] [Related]
11. Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis.
Beneit N; Fernández-García CE; Martín-Ventura JL; Perdomo L; Escribano Ó; Michel JB; García-Gómez G; Fernández S; Díaz-Castroverde S; Egido J; Gómez-Hernández A; Benito M
Cardiovasc Diabetol; 2016 Dec; 15(1):161. PubMed ID: 27905925
[TBL] [Abstract][Full Text] [Related]
12. Proprotein convertases regulate insulin-like growth factor 1-induced membrane-type 1 matrix metalloproteinase in VSMCs via endoproteolytic activation of the insulin-like growth factor-1 receptor.
Stawowy P; Kallisch H; Kilimnik A; Margeta C; Seidah NG; Chrétien M; Fleck E; Graf K
Biochem Biophys Res Commun; 2004 Aug; 321(3):531-8. PubMed ID: 15358140
[TBL] [Abstract][Full Text] [Related]
13. Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells.
Bouallegue A; Vardatsikos G; Srivastava AK
Can J Physiol Pharmacol; 2009 Dec; 87(12):1009-18. PubMed ID: 20029537
[TBL] [Abstract][Full Text] [Related]
14. [Effect of IGF-1 on PI3K/PTEN signal pathway in vascular smooth muscle cell].
Wu XL; Yang DY; Yang ZS; Wang SW; Zhao YS
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2004 Aug; 20(3):259-62. PubMed ID: 21192419
[TBL] [Abstract][Full Text] [Related]
15. Implication of insulin receptor A isoform and IRA/IGF-IR hybrid receptors in the aortic vascular smooth muscle cell proliferation: role of TNF-α and IGF-II.
Gómez-Hernández A; Escribano Ó; Perdomo L; Otero YF; García-Gómez G; Fernández S; Beneit N; Benito M
Endocrinology; 2013 Jul; 154(7):2352-64. PubMed ID: 23677929
[TBL] [Abstract][Full Text] [Related]
16. Sustained Akt/PKB activation and transient attenuation of c-jun N-terminal kinase in the inhibition of apoptosis by IGF-1 in vascular smooth muscle cells.
Allen RT; Krueger KD; Dhume A; Agrawal DK
Apoptosis; 2005 May; 10(3):525-35. PubMed ID: 15909115
[TBL] [Abstract][Full Text] [Related]
17. Impact of insulin-like growth factor-I on migration, proliferation and Akt-ERK signaling in early and late-passages of vascular smooth muscle cells.
Stratton MS; Yang X; Sreejayan N; Ren J
Cardiovasc Toxicol; 2007; 7(4):273-81. PubMed ID: 17960499
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase B/AKT mediates insulin-like growth factor 1-induced phosphorylation and nuclear export of histone deacetylase 5 via NADPH oxidase 4 activation in vascular smooth muscle cells.
Pietruczuk P; Jain A; Simo-Cheyou ER; Anand-Srivastava MB; Srivastava AK
J Cell Physiol; 2019 Aug; 234(10):17337-17350. PubMed ID: 30793765
[TBL] [Abstract][Full Text] [Related]
19. Bradykinin-induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K/Akt in vascular smooth muscle cells.
Yang CM; Lin MI; Hsieh HL; Sun CC; Ma YH; Hsiao LD
J Cell Physiol; 2005 Jun; 203(3):538-46. PubMed ID: 15573401
[TBL] [Abstract][Full Text] [Related]
20. (2S)-naringenin from Typha angustata inhibits vascular smooth muscle cell proliferation via a G0/G1 arrest.
Lee JJ; Yi H; Kim IS; Kim Y; Nhiem NX; Kim YH; Myung CS
J Ethnopharmacol; 2012 Feb; 139(3):873-8. PubMed ID: 22212500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
